If the vaccine rollout works like we hope it will, Jim Cramer says, the winning stocks of the post-COVID world include aerospace, retail, restaurants, autos and financials.

Biogen reports better-than-expected first-quarter earnings and says the pandemic brings "unanticipated and potentially unquantifiable risks to our business" near term.

Jim Cramer says fear is widespread, and it's impossible to call the bottom. But he recalls the wisdom of Warren Buffett.

Sangamo's stock price is surging after a pair of patients reported no bleeding events for as long as 24 weeks following treatment following investigational SB-525 gene therapy for severe hemophilia A.

The stock surges on 'encouraging' results from a genome-therapy trial for the treatment of a severe type of hemophilia.

Jim Cramer talks about how this market is taking its cues from the positives, and shrugging off the negatives.

Jim Cramer weighs in on Brinks, Sangamo Biosciences, Medtronic, Fiat Chrysler, GW Pharmaceuticals, EPR Properties.

Here's what you need to know now for Wednesday, Feb. 14.

Jim Cramer is bullish on Delta Air Lines, BioTelemetry, TransUnion, Amgen and Littelfuse.

The 14-week decline in gasoline prices ended while two million people in Florida are still without power.

A new EV would radically change how cars are made and that could be a threat to the market leader.

The fast-food giant rarely tweaks its morning menu, but it's making two big additions as potentially an answer to a huge Wendy's move.